390 related articles for article (PubMed ID: 30270054)
21. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
Latkovskis G; Saripo V; Gilis D; Nesterovics G; Upena-Roze A; Erglis A
Atherosclerosis; 2018 Oct; 277():347-354. PubMed ID: 30270070
[TBL] [Abstract][Full Text] [Related]
22. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".
Pang J; Hu M; Lin J; Miida T; Nawawi HM; Park JE; Wu X; Ramli AS; Kim NT; Kwok S; Gonzalez-Santos LE; Su TC; Truong TH; Soran H; Yamashita S; Tomlinson B; Watts GF
BMJ Open; 2017 Oct; 7(10):e017817. PubMed ID: 29074516
[TBL] [Abstract][Full Text] [Related]
23. Familial hypercholesterolaemia workshop for leveraging point-of-care testing and personalised medicine in association with the Lipid and Atherosclerosis Society of Southern Africa.
Marais AD; Kotze MJ; Raal FJ; Khine AA; Talmud PJ; Humphries SE
Cardiovasc J Afr; 2019; 30(5):297-304. PubMed ID: 31746944
[TBL] [Abstract][Full Text] [Related]
24. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration
Lancet; 2024 Jan; 403(10421):55-66. PubMed ID: 38101429
[TBL] [Abstract][Full Text] [Related]
25. Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry.
Brunham LR; Ruel I; Khoury E; Hegele RA; Couture P; Bergeron J; Baass A; Dufour R; Francis GA; Cermakova L; Mancini GBJ; Brophy JM; Brisson D; Gaudet D; Genest J
Atherosclerosis; 2018 Oct; 277():419-424. PubMed ID: 30270080
[TBL] [Abstract][Full Text] [Related]
26. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
[TBL] [Abstract][Full Text] [Related]
28. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia Including Registries.
Florentin M; Kostapanos MS; Elisaf MS; Liberopoulos EN
Curr Pharm Des; 2018; 24(31):3605-3615. PubMed ID: 30306861
[TBL] [Abstract][Full Text] [Related]
30. Managing homozygous familial hypercholesterolaemia from cradle to grave.
Thompson GR
Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
[TBL] [Abstract][Full Text] [Related]
31. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.
Buonuomo PS; Macchiaiolo M; Leone G; Valente P; Mastrogiorgio G; Gnazzo M; Rana I; Gonfiantini MV; Gagliardi MG; Romano F; Bartuli A
Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886
[TBL] [Abstract][Full Text] [Related]
32. Preliminary data of familial hypercholesterolemia (FH) patients in Romania.
Dumitrescu A; Mosteoru S; Vinereanu D; Dan GA; Gaita L; Gaita D
Atherosclerosis; 2018 Oct; 277():304-307. PubMed ID: 30270063
[TBL] [Abstract][Full Text] [Related]
33. New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.
Ellis KL; Pang J; Schultz CJ; Watts GF
Eur J Prev Cardiol; 2017 Jul; 24(11):1200-1205. PubMed ID: 28482694
[TBL] [Abstract][Full Text] [Related]
34. Familial hypercholesterolemia treatments: Guidelines and new therapies.
Raal FJ; Hovingh GK; Catapano AL
Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089
[TBL] [Abstract][Full Text] [Related]
35. The development of the Mexican Familial Hypercholesterolemia (FH) National Registry.
Mehta R; Martagon AJ; Galan Ramirez GA; Gonzalez Retana G; Martinez-Beltran M; Vargas Vazquez A; Vazquez-Cardenas A; Aguilar-Salinas CA
Atherosclerosis; 2018 Oct; 277():517-523. PubMed ID: 30270093
[TBL] [Abstract][Full Text] [Related]
36. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.
Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Mata P
Vasc Health Risk Manag; 2020; 16():11-25. PubMed ID: 32021224
[TBL] [Abstract][Full Text] [Related]
37. Homozygous familial hypercholesterolaemia: update on management.
France M
Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
[TBL] [Abstract][Full Text] [Related]
38. Familial hypercholesterolaemia: a model of care for Australasia.
Watts GF; Sullivan DR; Poplawski N; van Bockxmeer F; Hamilton-Craig I; Clifton PM; O'Brien R; Bishop W; George P; Barter PJ; Bates T; Burnett JR; Coakley J; Davidson P; Emery J; Martin A; Farid W; Freeman L; Geelhoed E; Juniper A; Kidd A; Kostner K; Krass I; Livingston M; Maxwell S; O'Leary P; Owaimrin A; Redgrave TG; Reid N; Southwell L; Suthers G; Tonkin A; Towler S; Trent R;
Atheroscler Suppl; 2011 Oct; 12(2):221-63. PubMed ID: 21917530
[TBL] [Abstract][Full Text] [Related]
39. Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry.
Pang J; Sullivan DR; Hare DL; Colquhoun DM; Bates TR; Ryan JDM; Bishop W; Burnett JR; Bell DA; Simons LA; Mirzaee S; Kostner KM; Nestel PJ; Wilson AM; O'Brien RC; Janus ED; Clifton PM; Ardill JJ; Chan DC; van Bockxmeer F; Watts GF;
Heart Lung Circ; 2021 Mar; 30(3):372-379. PubMed ID: 32873489
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017.
Pottle A; Thompson G; Barbir M; Bayly G; Cegla J; Cramb R; Dawson T; Eatough R; Kale V; Neuwirth C; Nicholson K; Payne J; Scott J; Soran H; Walji S; Watkins S; Weedon H; Nath Datta DB
Atherosclerosis; 2019 Nov; 290():44-51. PubMed ID: 31563836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
